Aug 12, 2019
News & Events
Press Releases
Jul 24, 2019
Salarius Pharmaceuticals Successfully Monetizes Legacy Consumer Product
Houston, TX – July 24, 2019 – Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of cancers, today announced it...
Jul 22, 2019
Salarius Pharmaceuticals Enrolls First Patient in a Phase 1 Clinical Study of its Novel Inhibitor Targeting Epigenetics in Patients with Advanced Solid Tumors
Houston, TX – July 22, 2019 – Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of cancers, today announced it...
Jul 22, 2019
Salarius Pharmaceuticals Announces Closing of Strategic Merger with Flex Pharma
To Begin Trading on Nasdaq Capital Market Today Under Ticker Symbol “SLRX” Houston, TX – July 22, 2019 – Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a...
Events
SALARIUS PHARMACEUTICALS, INC. RINGS THE NASDAQ STOCK MARKET OPENING BELL
Montauk Emerging Life Sciences Summit
World Orphan Drug Congress USA 2019
29th Annual Oppenheimer Healthcare Conference
In the News
Nasdaq